9^th Diabetologists Conference June 06-08, 2016 Dallas, Texas ,USA

Dharambir K. Sanghera is an Associate Professor in the University of Oklahoma Health Sciences Center, USA. Dr. Sanghera\'s research specializes in the study of molecular and genetic epidemiological aspects of common complex diseases including non-insulin dependent diabetes mellitus (T2D), coronary heart disease, hypertension, and metabolic syndrome. Common traits with complex inheritance have both genetic and environmental causes.

Diabetes, Cardiovascular disease, Obesity, Genetics and Genomics

Dr. Rayat’s research focus is to understand the mechanism(s) of islet xenograft rejection and to develop safer strategies for preventing rejection and induction of tolerance to islet xenografts. Despite the current success in this field of islet transplantation, two major problems need to be addressed so that this therapy can be applied to the majority of individuals with type 1 diabetes. These problems are shortage of human islets for transplantation and the chronic use of immunosuppressive drugs to prevent rejection of the transplant.

Islet xenotransplantation, tansplantation tolerance, autoimmunity (type 1 diabetes)

Dr. Gary Trager is an endocrinologist in Huntington, New York and is affiliated with Huntington Hospital. He received his medical degree from Universidad Central del Este Facultad de Medicina and has been in practice for 35 years. He is one of 5 doctors at Huntington Hospital who specialize in Endocrinology, Diabetes & Metabolism.hE IS THE PRESIDENT OF Americal Association of Clinical Endocrinology, lower NeW York.

Endocrinology, Diabetes & Metabolism and Diabetes.

Claude K Lardinois, MD, FACP, MACN is Emeritus Professor, Endocrinology Division, University of Nevada School of Medicine and Graduate Faculty for Nevada Studies in Nutrition at the University of Nevada, Reno, Nevada. He is an Endocrinology Consultant for Renown Health and Medical Director Disease Management, American Health Care, Rocklin, California. His research interests include work in nutrition, diabetes, hypertension, and dyslipidemia. He has a notable interest in eradicating heart disease, the major cause of death in the United States. Dr. Lardinois is a Fellow of the American College of Physicians (FACP), a Master of the American College of Nutrition (MACN) and a Fellow of the American College of Endocrinology (FACE). He is board certified in internal medicine and endocrinology and metabolism.

nutrition, diabetes, hypertension, and dyslipidemia. Especially interested in eradicating heart disease.

Triply post graduate in Medicine (MD), Nutrition (PGDND) and Radiology (DMRE), 64 years old Dr. Lakshmi K Shankhdhar, holds the credit of establishing North India’s still only exclusive Diabetes Clinic in Lucknow, India and is the fourth Indian to receive Wockhardt-Harvard Medical Excellence Award and Visiting Fellowship of Harvard Medical International, the International Arm of Harvard Medical School (Boston). He has presented several abstracts and Faculty orations in many International conferences on Diabetes, besides chairing some International conferences. Currently he is Principal of a medical College of Diabetology, besides working as Medical Director and Endocrinologist in his own Clinic, the LK Diabetes Centre.

Diabetes related Research

Dr. Vardi serves as the director of the central unit of Pediatric Endocrinology & Diabetes in Haifa. She is also the director of the laboratory for Diabetes & Obesity research in Felsenstein research center of the Sackler Faculty of Medicine in Tel Aviv University. Dr. Vardi is a board certified pediatrician, general endocrinologist and pediatric endocrinologist. She graduated from the Faculty of Medicine in the Technion, institute of technology in Haifa, Israel. She did her fellowship in Diabetes Research, at the Joslin Diabetes Center, Harvard Medical school. Her work involves both clinical and basic research with main focus on characterization and prevention of diabetes, metabolic syndrome and their complications. Recently she initiated a novel clinical approach to treat diabetes by involving all family members of diabetic subjects in the efforts to slow aging process induced by components of metabolic syndrome, where each family further distributes the knowledge to the close community. In her laboratory her team is involved in exploring islet transplantation, pancreatic islet biology and tissue engineering of bio-artificial pancreas. Dr Vardi is the founder and chairperson of Beta o2 biothechnologies. Her genetic research was selected in 1997 to represent the BSF contribution in science as special, outstanding and science news-worthy. The genetic locus found by her and her partners was titled by the HUGO as IDDM17. Recently her team is involved in evaluating a novel approach to treat chronic neurodegenerative diseases by islet transplantation in the brain. Dr. Vardi published above 100 peer reviewed scientific papers, is invited lecturer in various national and international meeting on diabetes and served as a member of various diabetes organizing and scientific committees. She also serves as a member of the WHO committee on classification of diabetes and its complications

Diabetes,Endocrinology

Dr. Giulio Maria Pasinetti is a Professor of Psychiatry, Professor of Neuroscience and Professor of Geriatrics and Adult Development, in the Department of Psychiatry at Mount Sinai School of Medicine, New York. Dr. Pasinetti graduated from Milan University School of Medicine in 1982, and he received his Ph.D. from the University of Milan in 1988. He joined the Mount Sinai School of Medicine\'s faculty in 1996 and has consistently maintained an outstanding record of excellence and exceptional productivity. Dr. Pasinetti is a recipient of several academic awards including the prestigious Zenith and Temple awards from the Alzheimer\'s Association. Dr. Pasinetti was recently awarded with an NIH funded research grant supporting a \'\'Center of Excellence for Research in Complementary and Alternative Medicine in Alzheimer\'s disease,\'\' of which he is the Principal Investigator and Director. Dr. Pasinetti also serves as the Director of the Basic and Biomedical Research and Training Program, GRECC James J. Peters Veterans Affairs Medical Center at the Bronx VA.

Alzheimer\'s Disease, Amyotrophic Lateral Sclerosis, Brain, Diabetes, Gene Therapy, Genomics, Inflammation, Insulin, Memory, Microarray, Muscular Dystrophy, Obesity, Proteomics, Synapses, Viruses and Virology,

Dr. Mohamad Navab has received his PhD in Biochemistry from NY Columbia University during the period of 1970 to 1976. Currently, Dr. Navab is working as Professor of Medicine/Cardiology in UCLA University. He has successfully completed his Administrative responsibilities as Project Leader. He is serving as an editorial member of several reputed journals. He has authored 160 research articles/books. He is a member of American Heart Association. He has been honored as a recipient of NIH post Doctoral Awards

Atherosclerosis, oral mimetic peptides, functional assays for lipoproteins.

Zhengyuan Xia is an associate professor in university of Hong kong, China.Zhengyuan Xia had served as a cardiovascular anesthetist for more than 10 years in China before he completed his Ph.D study at the University of British Columbia, in Canada in 2004. He is now Assistant Professor and Honorary Associate Professor and Deputy Director, Anesthesiology Research Laboratory of the Department of Anesthesiology, University of Hong Kong. His major focus of research is post-ischemic cardiac protection in diabetes. He has published more than 96papers in reputed journals (such as Diabetes, Free Radical Biology & Medicine, Critical Care Medicine) and is serving as an Executive Editor of Journal of Diabetes & Metabolism.

Reactive oxygen species signalling in diabetic cardiomyophathy, Antioxidant treatments for myocardial ischemia-reperfusion injury, Pharmacological (anesthetic) preconditioning and postconditioning

Dr. Joseph Fomusi Ndisang is an Associate Professor in the University of Saskatchewan College of Medicine, Department of Physiology. He received postdoctoral training in Physiology at the University of Saskatchewan College of Medicine from 200-2005. He received a PhD in Pharmacology & Toxicology from the University of Florence, Italy, 2000. He received a Doctor of Pharmacy degree from University of Florence, Italy in 1995. He has received several distinguished awards and distinctions including: Fellow of the American Heart Association (FAHA) in 2011; Fellow of the International College of Angiology (FICA) in 2007; Young Investigator Award by International College of Angiology (2007); Young Investigator Award by the American Society of Pharmacology & Experimental Therapeutics-Division for Drug Discovery, Development & Regulatory Affairs (2005); Young Investigator Award by the Society of Experimental Biology and Medicine (2005) He has published 36 manuscripts, 57 abstracts, 2 book chapters, 1 book and has served peer-reviewer for may highly reputed journals and funding agencies in United States, United kingdom and Canada and has also served as external PhD examiner in Canada and internationally .

His research interest is mainly focused on investigation the role of the heme oxygenase system in hypertension, diabetes (types-1 and -2), and obesity.

Dr. Paras Kumar Mishra did BSc and MS in Biological science with specialization in Zoology from India. His Ph.D. dissertation was from Banaras Hindu University (a reputed university in India) on understanding the genetic basis of speciation. His postdoctoral works was basically on cardiac physiology from USA. As a faculty, the major focus of our research is to understand how heart undergoes structural and functional remodeling especially in diabetes, how it is regulated by specific microRNA (miR). He was also interested in investigating the role of extracellular matrix (ECM) and matrix metalloproteinases (MMPs) in heart failure. Their recent results revealed that MMP9 and miR-133 plays pivotal role in diabetic cardiomyopathy. Since, the role of ECM stiffness is unequivocal in stem cell apoptosis, we are interested to investigate the mechanism of ECM mediated cardiac progenitor cell apoptosis / impairment of differentiation in diabetes. The long term goal of research is to discover an intervention tool to improve cardiac function in pathological heart using microRNAs and stem cells.

MicroRNomics of cardiovascular diseases , Diabetic cardiomyopathy

Dr. Sohal did his MD from the University of Alberta and PhD in Biochemistry from the University of Saskatchewan. He did his residency training in family medicine from the University of British Columbia. At present, he is a Family Physician and a Clinical Associate Professor at the Department of Family Practice, University of British Columbia in Vancouver, Canada. Dr. Sohal has published numerous research papers and presented abstracts at various national/international meetings. His main area of interest is prevention and management of diabetes particularly in South Asians. Dr. Sohal has been working with the Canadian Diabetes Association (CDA) both at the local and national levels since 2002. Dr. Sohal was a member of the CDA 2008 Clinical Practice Guidelines Expert Committee for the prevention and management of diabetes in Canada. He has received several awards including CDA 2009 National Volunteer of the Year Award and 2014 Frederick Banting Award from the CDA. He was awarded 2014 Canada’s Family Physician of the Year Award for BC by the College of Family Physicians of Canada.

Prevention and management of diabetes and cardiovascular disease , Clinical trial on diabetes, Dyslipidemia

Dr. Jallo, an Associate Professor of Medicine & Senior Consultant Endocrinologist. He granted his MB, ChB from Mosul University College of Medicine in IRAQ 1981, his postgraduate Arab Board Certification in Internal Medicine CABM in1992, Fellowship of The American College of Endocrinology FACE in 2015 and certified with Diploma in Dyslipidemia from Boston University School of Medicine, USA in 2014. He is the Coordinator for MBBS Endocrinology Module in GMU, Editorial Board for many international journals and active Principle Investigator in many national & international clinical studies, Member of AACE, EASD, ESE, ISPAD and many professional societies. To his credit many awards of honor & publications in medical periodicals and conference abstracts.

Endocrinology, Diabetes

Alireza Jahan-Mihan ultimate research goal is to unveil the role of functional foods and their dietary bioactive components in health and diseases. Understanding the mechanisms by which bioactive food components influence the risk of development of characteristics of metabolic syndrome including diabetes mellitus, dyslipidemia, hypertension and obesity and also factors affecting appetite and food intake regulatory system is my particular interest. The specific focus of my research program is on physiological and nutritional functions of dietary proteins and peptides. Both animal and clinical approaches are applied to reveal underlying mechanisms of functional foods and also to examine the applicability of research outcomes. It helps to transfer knowledge and findings from lab bench to the community level and facilitate collaboration between academia, community and food industry.

Functional foods, Dietary proteins, Development, Aging, Food intake regulatory system, Metabolic syndrome, obesity.

Bruno Doiron, Ph.D is an Assistant Professor at the University Of Texas Health Science Center at San Antonio. He received his undergraduate degree from University of Moncton, N.B. Canada and graduate degrees from University of Montreal, QC, Canada and University of Paris Descartes, Paris, France. As project leader he has made major discoveries in the field of gene regulation by nutrients and has 3 patents on the modulation of glucose metabolism as it relates to the treatment diabetes and cancer. Dr. Doiron has extensive experience in basic research at the physiologic and molecular levels and in respective applications to the biotechnology field.

Physiology, Endocrinology, Systems Biology, Pancreatic Cancer, Diabetes Mellitus Type 2, Type 1 Diabetes Mellitus, Diabetes Drug Development,

Rachel Pessah-Pollack, M.D., F.A.C.E. completed her Internal Medicine residency and Endocrinology fellowship at Mount Sinai School of Medicine in New York City, after which ProHEALTH was pleased to welcome her to our Division of Endocrinology. She is Board Certified in Internal Medicine and Endocrinology, Diabetes and Metabolism and as a Physician Nutrition Specialist. She is an Assistant Clinical Instructor of Medicine at the Mount Sinai School of Medicine and a coauthor of the American Association of Clinical Endocrinologists (AACE) Hypothyroid Guidelines published in 2012 and Osteoporosis Guidelines published in 2010. Dr. Pessah-Pollack edited a book, “Endocrine Disorders During Pregnancy, An Issue of Endocrinology and Metabolism Clinics of North America” in 2011. She has a special interest in pregnancy-related endocrine disorders and thyroid disease and performs ultrasound-guided fine needle aspiration biopsies of thyroid nodules.

Endocrinology, Diabetes and Bone Disease